Concepedia

Publication | Open Access

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

DOIFull Paper Access

44

Citations

11

References

2012

Year

J. Alexandre, Chris Brown, David Coeffic, Nadia Raban, Jacobus Pfisterer, Johanna Mäenpää, Haji Chalchal, Bernard M. Fitzharris, Birgit Volgger, Ignace Vergote,
British Journal of Cancer

Abstract

CA-125 and radiological tests performed similarly in determining progression with C-PLD or C-P. Additional follow-up with CA-125 measurements was not associated with overtreatment.

References

YearCitations

Page 1